Clinical Trial: GLIDE Regiment Followed by ASCT for Aggressive NK/T Cell Lymphoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Study of Gemcitabine, L- Asparaginase, Ifosfamide, Dexamethasone and Etoposide Chemotherapy Followed by ASCT for Newly Diagnosed Stage IV, Relapsed or Refractory Extranodal Natural Killer/T-cell Lym

Brief Summary: This study is to explore the efficacy and safety of GLIDE regiment in patients with aggressive NK/T cell lymphoma.